These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 33219474)
1. An Investigation into Proteomic Constituents of Cerebrospinal Fluid in Patients with Chronic Peripheral Neuropathic Pain Medicated with Opioids- a Pilot Study. Royds J; Cassidy H; Conroy MJ; Dunne MR; Matallanas D; Lysaght J; McCrory C J Neuroimmune Pharmacol; 2021 Sep; 16(3):634-650. PubMed ID: 33219474 [TBL] [Abstract][Full Text] [Related]
2. Examination and characterisation of burst spinal cord stimulation on cerebrospinal fluid cellular and protein constituents in patient responders with chronic neuropathic pain - A Pilot Study. Royds J; Conroy MJ; Dunne MR; Cassidy H; Matallanas D; Lysaght J; McCrory C J Neuroimmunol; 2020 Jul; 344():577249. PubMed ID: 32361148 [TBL] [Abstract][Full Text] [Related]
3. Control of neuropathic pain by immune cells and opioids. Machelska H CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):559-70. PubMed ID: 21631408 [TBL] [Abstract][Full Text] [Related]
4. Opioids and neuropathic pain. Smith HS Pain Physician; 2012 Jul; 15(3 Suppl):ES93-110. PubMed ID: 22786465 [TBL] [Abstract][Full Text] [Related]
5. Pain responsiveness to opioids: central versus peripheral neuropathic pain. Smith HS; Meek PD J Opioid Manag; 2011; 7(5):391-400. PubMed ID: 22165038 [TBL] [Abstract][Full Text] [Related]
6. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
7. Trends in opioid use for chronic neuropathic pain: a survey of patients pursuing enrollment in clinical trials. Gilron I; Bailey JM Can J Anaesth; 2003 Jan; 50(1):42-7. PubMed ID: 12514149 [TBL] [Abstract][Full Text] [Related]
8. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study. Simpson DM; Messina J; Xie F; Hale M Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282 [TBL] [Abstract][Full Text] [Related]
9. Examination and characterisation of the effect of amitriptyline therapy for chronic neuropathic pain on neuropeptide and proteomic constituents of human cerebrospinal fluid. Royds J; Cassidy H; Conroy MJ; Dunne MR; Lysaght J; McCrory C Brain Behav Immun Health; 2021 Jan; 10():100184. PubMed ID: 34589721 [TBL] [Abstract][Full Text] [Related]
10. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain. Leung A; Wallace MS; Ridgeway B; Yaksh T Pain; 2001 Mar; 91(1-2):177-87. PubMed ID: 11240090 [TBL] [Abstract][Full Text] [Related]
11. The importance of chemokines in neuropathic pain development and opioid analgesic potency. Kwiatkowski K; Mika J Pharmacol Rep; 2018 Aug; 70(4):821-830. PubMed ID: 30122168 [TBL] [Abstract][Full Text] [Related]
12. Methadone for neuropathic pain in adults. McNicol ED; Ferguson MC; Schumann R Cochrane Database Syst Rev; 2017 May; 5(5):CD012499. PubMed ID: 28514508 [TBL] [Abstract][Full Text] [Related]
13. Preliminary study of the plasma and cerebrospinal fluid concentrations of IL-6 and IL-10 in patients with chronic pain receiving intrathecal opioid infusions by chronically implanted pump for pain management. Zin CS; Nissen LM; O'Callaghan JP; Moore BJ; Smith MT Pain Med; 2010 Apr; 11(4):550-61. PubMed ID: 20202139 [TBL] [Abstract][Full Text] [Related]
15. Stronger antinociceptive efficacy of opioids at the injured nerve trunk than at its peripheral terminals in neuropathic pain. Labuz D; Machelska H J Pharmacol Exp Ther; 2013 Sep; 346(3):535-44. PubMed ID: 23820126 [TBL] [Abstract][Full Text] [Related]
16. Attenuation of ongoing neuropathic pain by peripheral acting opioid involves activation of central dopaminergic neurocircuitry. Vaidya S; Shantanu PA; Tiwari V Neurosci Lett; 2021 May; 754():135751. PubMed ID: 33610665 [TBL] [Abstract][Full Text] [Related]
17. Opioids and TRPV1 in the peripheral control of neuropathic pain--Defining a target site in the injured nerve. Labuz D; Spahn V; Celik MÖ; Machelska H Neuropharmacology; 2016 Feb; 101():330-40. PubMed ID: 26453963 [TBL] [Abstract][Full Text] [Related]
18. Pregabalin vs. opioids for the treatment of neuropathic cancer pain: a prospective, head-to-head, randomized, open-label study. Raptis E; Vadalouca A; Stavropoulou E; Argyra E; Melemeni A; Siafaka I Pain Pract; 2014 Jan; 14(1):32-42. PubMed ID: 23464813 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the use of opioids only and pregabalin add-on for the treatment of neuropathic pain in cervical myelopathy patients: a pilot trial. Jung JM; Chung CK; Kim CH; Yang SH; Choi Y Sci Rep; 2020 May; 10(1):8120. PubMed ID: 32415211 [TBL] [Abstract][Full Text] [Related]
20. Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy. Kwiatkowski K; Pawlik K; Ciapała K; Piotrowska A; Makuch W; Mika J Front Immunol; 2020; 11():615327. PubMed ID: 33408720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]